Over-the-Counter Market Quotations
نویسندگان
چکیده
منابع مشابه
Maker-Taker Pricing Effects on Market Quotations
The exchange maker-taker pricing scheme affects incentives to take or make markets resulting in narrower bid-ask spreads. This study traces the effect of maker-taker pricing on stock quotations. The analyses consider distributions of quotation sizes, values implied from these sizes, and changes in these sizes and values. The results help inform the current debate on whether tick sizes should be...
متن کاملThe nature of Over the Counter market and its distinction from Stock Exchange in Iran and the US Legal systems
Although clause 8 of article 1 of the Securities Market Act has been explained Over the Counter market and defined it to ”an electronic or non-electronic market which implements securities transactions on the basis of negotiations”, according to some changes in the rules and regulations of this section, including approval of Iranian Securities Market Act, The law for Development of New Financia...
متن کاملThe over-the-counter pharmaceutical market – policy and practice
POM medicines are primarily only available to the public when prescribed by a medical practitioner, although historically dentists have long been able to supply from a limited Dental Formulary. More recently in the UK, full prescribing rights have also been accorded to other health care professionals such as nurses and pharmacists, as long as certain specified conditions are met. P medicines ca...
متن کاملLiquidity misallocation in an over-the-counter market
We show that the dispersion of private valuation reduces market liquidity and allocative e ciency of a dynamic OTC market. In this decentralized market, traders have time varying and heterogeneous private value over the asset and dealers act as competing mechanism designers. We characterize the optimal liquidity provision with endogenous valuation, outside options and type distributions. Depend...
متن کاملOver-the-counter statins.
In late 2004, the British government decided to allow a lipid-lowering agent to be sold as an over-the-counter medication. In contrast, the U.S. Food and Drug Administration recently decided not to do so. The United States and other countries will soon face similar decisions for other statins. Although statins have infrequent side effects and have been shown to be effective in moderate-risk pri...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Michigan Law Review
سال: 1964
ISSN: 0026-2234
DOI: 10.2307/1286656